Company news
Jiangsu Bioperfectus Technologies Co. Ltd. Class A (SSE:688399) news
Jiangsu Bioperfectus Technologies Co. Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: "Jiangsu Bioperfectus Technologies Co., Ltd."Announcement…
Press releases & updates
"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 28, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
September 24, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Indicative Announcement on Change of the Executive Partner of the Partnership and Change in Equity Interests of Shareholders
September 21, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Indicative Announcement on Postponement of Election of New Board of Directors
September 20, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Change in Accounting Policies
August 27, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Indicative Announcement on the Termination of the Acting-in-Concert Relationship among Relevant Shareholders and the Change of the Actual Controller
July 29, 2026
"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Implementation of Dividend Distribution for 2025
July 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 24, 2026
Announcement on Voluntary Disclosure of Changing Medical Device Registration Certificate
June 18, 2026
Notice on Convening the 2025 Annual General Meeting
June 3, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
May 6, 2026
Report for Q1 2026
April 29, 2026
Announcement on 2025 Plan for Profit Distribution and Share Capital Increased from Transfer of Capital Reserve
April 22, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on the Reversal of Bad Debt Provision for Some Accounts Receivable
January 18, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 5, 2026
Announcement on Obtaining Government Subsidies
January 4, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
December 15, 2025
Announcement on Voluntary Disclosure of Company Products Being Included in the WHO Emergency Use Listing
December 7, 2025
Announcement on Renewal of the Concerted Action Agreement by the Actual Controller
December 5, 2025
Announcement on Election of Employee Director
November 11, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
October 24, 2025
Announcement on the Death of Director and Deputy General Manager
September 12, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 4, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 27, 2025
Announcement on Convening the 2025 Semi-annual Performance and Cash Dividend Briefing
August 18, 2025
Announcement on Provision and Reversal of Asset Impairment in the First Half of 2025
August 8, 2025
Announcement on Resignation of Deputy General Manager
August 1, 2025
Announcement on Progress in Changes in Equity Structure of Controlling Shareholder
July 22, 2025
Indicative Announcement on Changes in Equity Structure of Controlling Shareholder
July 15, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 6, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 28, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 27, 2025
Notice on Convening the 2024 Annual General Meeting
May 6, 2025
Announcement on Provision and Reversal of Asset Impairment in Q1 2025
April 29, 2025
Special Report on Annual Deposit and Actual Use of Raised Funds in 2024
April 18, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Annual Earnings Preannouncement for 2024
January 24, 2025
Announcement on Amending and Formulating Some Governance Systems
December 27, 2024
Announcement on Renewal of Concerted Action Agreement by Actual Controller
December 5, 2024
Announcement on Convening Q3 2024 Performance Briefing
November 15, 2024
Report for Q3 2024
October 25, 2024
Indicative Announcement on Equity Change Exceeding 1% by Controlling Shareholder and Persons Acting in Concert
October 17, 2024
Announcement on Implementation Results of Share Repurchase and Share Changes
October 15, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
October 10, 2024
Announcement on Serious Abnormal Fluctuations in Stock Trading
October 9, 2024
Announcement on Abnormal Fluctuations in Stock Trading
October 8, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 26, 2024
Announcement on Repurchasing 3% of the Company's Share Capital through Call Auction and Repurchase Progress
September 23, 2024